We are excited to announce that Active Needle Technology Ltd. has developed the world’s first ultrasonic tattoo device, Tranquill™, for medical and non-medical applications.

Initial testing, conducted by an experienced tattoo artist on human volunteer, has confirmed significant reduction (>50%) in pain compared with the market leading device. We are looking forward to commercialising the Tranquill™ in the near future and realising its potential in the multi-billion pound global tattoo market.

We'd like to take this opportunity to thank Innovate UK for supporting the project.

Previous
Previous

Active Needle Technology Ltd. is excited to announce the latest pre-clinical news about its HyPerfuse Needle™.

Next
Next

We are delighted to announce the grant of our first patent in low-pain ultrasonic needles. The technology opens a range of high-value applications in medical, healthcare and cosmetic markets.